glycyl-histidyl-lysine raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-10-09 and is reviewed periodically as new material appears.
Practical handling notes centre on limiting exposure to water, oxygen, and repeated temperature cycling. Weighed powder is often equilibrated to room temperature before opening to avoid condensation on the solid. Working solutions are typically divided into single-use aliquots and frozen rather than stored refrigerated for long periods. Reported shelf lives vary widely between laboratories, and no single set of conditions is universally treated as a reference standard, which complicates direct comparison of published stability figures.
Solutions of GHK-Cu respond strongly to pH, redox conditions, and the presence of competing chelators such as EDTA. Below roughly pH 4 the copper tends to dissociate, because the amide nitrogen donors become protonated and can no longer coordinate. Strongly alkaline conditions instead favour hydrolysis and precipitation of copper hydroxide. Dissolved oxygen and light accelerate breakdown of the peptide backbone, and the copper released during that process can catalyse further oxidation, so dry, cold, dark storage is the usual recommendation.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide backbone consists of glycine, histidine, and lysine joined in that order. Copper is held through the imidazole nitrogen of histidine and the alpha-amino group at the N-terminus, which together produce a square-planar arrangement around the metal center. The solid appears blue to violet, a color that originates from d-d electronic transitions within the copper coordination sphere. The complex is indexed under CAS number 89030-95-5.
The sequence now called GHK was first reported in the early 1970s after isolation from human plasma, where it was noted to influence liver cell behavior in laboratory preparations. Later work described a copper-binding form and its activity in fibroblast and wound-model experiments. Review articles frequently group the substance with other copper peptides. Concentrations in blood appear to fall with age in several small surveys, although the reason for this trend is not settled. Whether such a decline carries functional consequences remains an open question.
Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.
| Property | Value | Notes |
|---|---|---|
| Typical peptide purity | 95% or higher by HPLC | Research-grade material; varies by supplier |
| Copper-to-peptide ratio | Approximately 1 to 1 | Determined by elemental analysis plus peptide assay |
| Visible absorption | Roughly 525 to 600 nm | Position shifts with pH and coordination state |
| Common counter-ions | Acetate, trifluoroacetate | Affect mass, solubility, and handling behaviour |
| Preferred storage form | Lyophilised powder, desiccated | Cold and dark; solutions are markedly less stable |
Research interest in GHK-Cu centers on its ability to deliver copper and to influence cellular processes in laboratory models. In cell culture and animal studies, the complex has been linked to collagen synthesis, antioxidant enzyme activity, and expression of genes associated with tissue remodeling. These effects are not equivalent to proven clinical outcomes. The mechanisms proposed include copper transfer to cuproenzymes, modulation of growth factor signaling, and interactions with extracellular matrix components. How much of the observed activity depends on intact GHK-Cu versus free copper or free peptide is not fully resolved.
The compound entered scientific literature in the 1970s, when plasma factors with copper-binding activity were isolated and characterized. Later work expanded into wound healing, skin biology, and cosmetic formulation, where copper tripeptide-1 became a recognized ingredient name. Most published studies remain preclinical or small-scale, and findings are often reported in specialized dermatology or peptide journals. Regulatory treatment varies: some jurisdictions allow it as a cosmetic ingredient, while research-grade material is sold for laboratory use. Questions about optimal delivery, target tissues, and long-term effects continue to be investigated rather than settled.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide sequence is often abbreviated Gly-His-Lys, and the copper is bound through the histidine imidazole nitrogen and adjacent peptide nitrogens. The complex is frequently described as a 1:1 peptide-to-copper species. It occurs naturally in human plasma, saliva, and urine at low concentrations. Its endogenous levels have been reported to decline with age, although the precise physiological role of that change remains an open question.
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence found naturally in human plasma, saliva and urine. Loren Pickart reported the isolation of the free peptide in 1973 while studying factors that influenced the growth of aged liver cells in culture. The peptide was later shown to bind copper(II) with high affinity, and the metal-bound form became the focus of most subsequent research. Its concentration in circulation declines markedly with age, a pattern that is well documented, though the physiological consequences of that decline remain debated.
The peptide portion consists of three amino acids: glycine, histidine and lysine. Copper(II) coordinates through the imidazole nitrogen of histidine, the alpha-amino group of glycine and a deprotonated amide nitrogen of the backbone, producing a roughly square-planar geometry. This arrangement gives the complex its characteristic blue-to-violet colour and helps it resist dissociation in water. Reported stability constants are high, although values differ between studies because of differences in ionic strength and measurement method.
The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.
=== Prenatal tests === A prenatal test can be considered when the mother is a known or suspected carrier. Before invasive testing, determination of the fetal sex is important; while males are sometimes affected by this X-linked disease, female Duchenne muscular dystrophy is extremely rare. This can be achieved by ultrasound scan at 16 weeks or more recently by free fetal DNA (cffDNA) testing. Chorion villus sampling (CVS) can be done at 11–14 weeks and has a 1% risk of miscarriage. Amniocentesis can be done after 15 weeks and has a 0.5% risk of miscarriage. Non invasive prenatal testing can be done around 10–12 weeks. Another option in the case of unclear genetic test results is fetal muscle biopsy.
==== 300–399 ==== Goods Vehicles (Operators' Licences, Qualifications and Fees) (Amendment) Regulations 1993 (S.I. 1993/301) Mines (Shafts and Winding) Regulations 1993 (S.I. 1993/302) Housing (Right to Buy) (Priority of Charges) Order 1993 (S.I. 1993/303) Mortgage Indemnities (Recognised Bodies) Order 1993 (S.I. 1993/304) Folkestone-Brighton-Southampton-Dorchester-Honiton Trunk Road (Guestling Thorn Diversion) (Revocation) Order 1993 (S.I. 1993/305) Local Authorities (Capital Finance) (Rate of Discount for 1993/94) Regulations 1993 (S.I. 1993/312) Police (Amendment) Regulations 1993 (S.I. 1993/313) Gipsy Encampments (City and District of St. Albans) Order 1993 (S.I. 1993/314) Income-related Benefits Schemes (Miscellaneous Amendments) Regulations 1993 (S.I. 1993/315) Social Security (Invalid Care Allowance) Amendment Regulations 1993 (S.I. 1993/316) Housing Benefit (General) Amendment Regulations 1993 (S.I. 1993/317) Humberside Ambulance Service National Health Service Trust (Establishment) Amendment Order 1993 TI> S.I. 1993/318) Maidstone Priority Care National Health Service Trust (Establishment) Amendment Order 1993 (S.I. 1993/319) Royal Bournemouth and Christchurch Hospitals National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/320) Caledonian MacBrayne Limited (Armadale) Harbour Revision Order 1992 S.I. 1993/321) Revenue Support Grant (Scotland) Order 1993 (S.I. 1993/322) Town and Country Planning (Hazardous Substances) (Scotland) Regulations 1993 (S.I. 1993/323) A23 Trunk Road (Streatham High Road, Lambeth) (Box Junction) Order 1993 (S.I.
S-Glutathionylation is the posttranslational modification of protein cysteine residues by the addition of glutathione, the most abundant and important low-molecular-mass thiol within most cell types. Protein S-glutathionylation is involved in the following:
Sources: en.wikipedia.org
small/non-small cell lung cancer oesophageal cancer uterine cervical cancer urothelial cancer testicular cancer ovarian cancer prostate cancer head and neck cancer Nedaplatin is most often compared to other platinum-based drugs, most notably cisplatin. Many randomized controlled trials have been performed to compare nedaplatin and cisplatin, with uncertain results. One meta-analysis of 14 trials indicated no difference in efficacy in terms of median overall survival. Another meta-analysis of 17 trials looking specifically at concurrent chemoradiotherapy treatment for cervical cancer also found no difference in 3 year all-cause mortality, but did favour nedaplatin for 1 year all-cause mortality.
11 April – A study confirms antidepressant potential of psilocybin therapy protocols (which use the active ingredient in psilocybin mushrooms), providing fMRI data about a correlated likely major effect mechanism – global increases in brain network integration. 12 April – Science and the 2022 Russian invasion of Ukraine:An editorial in a scientific journal reports that relevant areas of food system research are patchy and lack independent assessments. An editorial projects significant gender and age imbalance in the population in Ukraine as a substantial problem if most refugees, as in other cases, do not return over time (4 Apr). A preprint reports impacts of the Ukrainian power grid synchronization with Continental Europe (15 Apr).
As a result, while the use of 1–3 mm microbore columns and lower flow rates of 50–200 μl/min was commonly considered necessary for optimum operation in the past, this limitation is no longer as important, and the higher column capacity of larger bore columns can now be advantageously employed with ESI LC–MS systems. Positively and negatively charged ions can be created by switching polarities, and it is possible to acquire alternate positive and negative mode spectra rapidly within the same LC run. While most large molecules (greater than MW 1500–2000) produce multiply charged ions in the ESI source, the majority of smaller molecules produce singly charged ions.
=== The Flory convention === see Flory convention for details. In modeling the position vectors of atoms in macromolecules it is often necessary to convert from Cartesian coordinates (x,y,z) to generalized coordinates. The Flory convention for defining the variables involved is usually employed. For an example, a peptide bond can be described by the x,y,z positions of every atom in this bond or the Flory convention can be used. Here one must know the bond lengths
Sources: en.wikipedia.org
Inductively coupled plasma mass spectrometry or atomic absorption spectroscopy gives total copper after acid digestion. Combining that value with a peptide concentration from chromatography or amino acid analysis yields the metal-to-peptide ratio.
The colour arises from electronic transitions within the copper(II) d orbital set, which absorb visible light. The absorption maximum shifts with pH and with the number of nitrogen donors bound, so the spectrum serves as a rough probe of coordination state.
Aqueous solutions degrade faster than dry powder, because hydrolysis, oxidation, and metal dissociation all proceed in water. Dividing solutions into small aliquots and freezing them limits repeated freeze-thaw cycles. Exact shelf lives are not well established and depend on concentration and buffer.
It is the copper complex of the tripeptide glycyl-L-histidyl-lysine. The metal ion is held by the histidine imidazole group and the peptide N-terminus. Most research on it concerns skin and wound models.